Local Tech Wire

RESEARCH TRIANGLE PARK, N.C. – , a provider of drug development and manufacturing services, has landed an expanded contract with drug giant Merck.

Financial terms were not disclosed.

Patheon will provide Merck a variety of services from its eight facilities worldwide,

"We have developed a great partnership with Merck and are very pleased that they have chosen to expand it with this contract manufacturing agreement," said Wes Wheeler, chief executive officer of Patheon, in a statement. "We are 100 percent focused on being the best service provider to our clients. This expanded contract with Merck validates that we are making great progress towards meeting this goal."

Get the latest news alerts: Follow